Skip to content
I grew up like any other American girl—with big ’80s hair and listening to way too much Depeche Mode—but I knew my heritage and […]
Asian American and Pacific Islanders: Common concerns amid a wealth of diversity Read More »
The Biotechnology Innovation Organization (BIO) International Convention is set to welcome Dr. Robert Califf, Commissioner of the U.S. Food and Drug Administration (FDA), as
FDA Commissioner to headline BIO International Convention Read More »
Key legislation providing greater transparency and oversight into the 340B federal drug program moved forward in the U.S. House on May 25. The House
340B legislation advances in U.S. House Read More »
A group of researchers compiled the most important questions facing the plant science community. As it turns out, biotech can provide answers and solutions
100 questions facing plant science – and how biotech can answer them Read More »
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »
As the Biotechnology Innovation Organization (BIO) prepares for the June 5-8 International Convention in Boston, the I am BIO Podcast explores how that city
I am BIO podcast explores how Boston became a ‘biotech hub’ Read More »
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be
Why Congress must repeal the R&D amortization provision Read More »
In a groundbreaking move towards advancing gene therapy research and treatment options for rare diseases, the Foundation for the National Institutes of Health (FNIH)
National Women’s Health Week brought a groundbreaking development: the approval of a new treatment option for hot flashes caused by menopause. On May 12,
FDA approves new treatment for menopause hot flashes Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
